It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 03555cam 2200841 a 4500
001 ocm19764893
003 OCoLC
005 20200515150842.0
008 890607s1989 nyua b 100 0 eng
010 $a 89149399
040 $aDLC$beng$cDLC$dNLM$dOCL$dMUQ$dBAKER$dBTCTA$dYDXCP$dOCLCG$dCRU$dZWZ$dBDX$dGBVCP$dOCLCO$dOCLCF$dOCLCQ$dOCL$dOCLCQ$dCASUM$dOCLCO
016 7 $a8915882$2DNLM
019 $a19804735$a20896221$a1013378877
020 $a0879693282
020 $a9780879693282
035 $a(OCoLC)19764893$z(OCoLC)19804735$z(OCoLC)20896221$z(OCoLC)1013378877
050 00 $aRS200$b.T47 1989
050 14 $aRM666.P415$bT484 1989
060 00 $aQU 68$bT3984 1988
082 00 $a615/.19$220
245 00 $aTherapeutic peptides and proteins :$bformulation, delivery, and targeting /$cedited by Daniel Marshak, Darrell Liu.
260 $aCold Spring Harbor, New York :$bCold Spring Harbor Laboratory,$c1989.
300 $axii, 215 pages :$billustrations ;$c22 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aCurrent communications in molecular biology
504 $aIncludes bibliographical references.
650 0 $aDrugs$xDosage forms$vCongresses.
650 0 $aPeptides$xTherapeutic use$vCongresses.
650 0 $aProteins$xTherapeutic use$vCongresses.
650 0 $aDrug targeting$vCongresses.
650 6 $aMédicaments$xFormes pharmaceutiques$xCongrès.
650 6 $aProtéines$xEmploi en thérapeutique$xCongrès.
650 6 $aPeptides$xEmploi en thérapeutique$xCongrès.
650 7 $aDrug targeting.$2fast$0(OCoLC)fst00898709
650 7 $aDrugs$xDosage forms.$2fast$0(OCoLC)fst00898801
650 7 $aPeptides$xTherapeutic use.$2fast$0(OCoLC)fst01057582
650 7 $aProteins$xTherapeutic use.$2fast$0(OCoLC)fst01079767
650 7 $aPeptides$xEmploi en thérapeutique$xCongrès.$2ram
650 7 $aProtéines$xEmploi en thérapeutique$xCongrès.$2ram
650 7 $aPharmacologie clinique$xCongrès.$2ram
651 4 $aBanbury Center.
650 2 $aDosage Forms.$0https://id.nlm.nih.gov/mesh/D004304
650 2 $aDrug Administration Routes.$0https://id.nlm.nih.gov/mesh/D004333
650 2 $aPeptides$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D010455Q000627
650 2 $aProteins$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D011506Q000627
653 0 $aDrug$aCongresses
653 0 $aDrug targeting$aCongresses
653 0 $aDrugs$aDosage$aCongresses
653 0 $aDrugs$aDosage forms$aCongresses
653 0 $aPeptides$aTherapeutic$aCongresses
653 0 $aPeptides$aTherapeutic use$aCongresses
653 0 $aProteins$aTherapeutic$aCongresses
653 0 $aProteins$aTherapeutic use$aCongresses
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 4 $aCongresses.
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aMarshak, Daniel R.
700 1 $aLiu, Teh-Yung,$d1932-
830 0 $aCurrent communications in molecular biology.
938 $aBaker & Taylor$bBKTY$c24.00$d24.00$i0879693282$n0001693986$sactive
938 $aBrodart$bBROD$n40534952$c$24.00
938 $aBaker and Taylor$bBTCP$n89149399
938 $aYBP Library Services$bYANK$n948343
029 1 $aAU@$b000006545620
029 1 $aGBVCP$b026123746
029 1 $aGBVCP$b043242006
029 1 $aNLM$b8915882
029 1 $aNZ1$b3613724
029 1 $aUNITY$b054671892
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 123 OTHER HOLDINGS